About Regorafenib Tablets BP
Experience the invincible efficacy of Regorafenib Tablets BP, preeminent in the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma. Each valiant tablet contains 40 mg Regorafenib in a blister pack of 28, ensuring precise dosing for adult patients. Shop Now and take advantage of our exclusive offer for distributors, exporters, suppliers, and traders in India. Administered orally and compliant with BP standards, these light brown, film-coated tablets deliver multi-targeted tyrosine kinase inhibition. Try Now under prescription and trusted local regulatory authorization.
Key Features & Application of Regorafenib Tablets BP
Regorafenib Tablets BP are multi-targeted tyrosine kinase inhibitors, offering valiant solutions for challenging oncology cases. Used primarily for adult patients, they address metastatic colorectal cancer, GIST, and hepatocellular carcinoma. The oral administration format ensures convenient application in hospitals, clinics, and oncology centers. Their film-coated texture and regulated dosage make them preeminent in modern cancer therapy, supporting enhanced patient management and clinical efficacy.
Certifications, Sample Policy & Logistics for Regorafenib Tablets BP
Regorafenib Tablets BP meet strict BP (British Pharmacopoeia) standards, ensuring regulatory compliance and safety for all exports. Samples are available subject to quotation, optimizing expenditure for bulk orders. With logistics centered around major FOB ports in India, clients benefit from streamlined delivery and dependable supply chains. Request your quotation now and facilitate access to these invincible cancer treatment tablets.
FAQ's of Regorafenib Tablets BP:
Q: How is Regorafenib Tablets BP administered to patients?
A: Regorafenib Tablets BP are administered orally as film-coated tablets, ensuring easy and direct intake for adult patients. Each pack contains 28 tablets, facilitating convenient dosing schedules as prescribed by oncologists.
Q: What conditions are treated with Regorafenib Tablets BP?
A: These tablets are used for the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma in adults, offering vital support as part of comprehensive oncology care.
Q: When should patients start using Regorafenib Tablets BP?
A: Patients begin Regorafenib treatment as directed by their healthcare professionals, typically upon diagnosis and confirmation of eligibility for metastatic cancers or GIST, following local regulatory approval and prescription guidelines.
Q: Where can I purchase Regorafenib Tablets BP?
A: Regorafenib Tablets BP is available through authorized distributors, exporters, suppliers, and traders in India, strictly via prescription and regulatory channels. Inquiries for bulk orders and samples can be routed through approved contacts.
Q: What certification standards do Regorafenib Tablets BP adhere to?
A: Regorafenib Tablets BP are manufactured in alignment with BP (British Pharmacopoeia) standards and comply with local regulatory authorizations, ensuring high safety and efficacy for export and distribution.
Q: What are the storage and shelf-life recommendations for Regorafenib Tablets BP?
A: Store Regorafenib Tablets below 25C, protected from moisture and light, with a shelf life of 24 months to maintain optimal potency and safety profiles.